ArticleJournal of controlled release : official journal of the Controlled Release Society2013

PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases.

Lisa M Kaminskas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.